Health
Asian nations scale back AstraZeneca rollout amid safety woes – The Japan Times
The moves may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.
Countries across the Asia Pacific are demurring on AstraZeneca PLCs COVID-19 vaccine, or restricting its use, in moves that may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.
After guiding against the vaccines use in people under 50 and saying that it didnt expect shipments from Europe to arrive on time, Australias government abandoned a pledge that everyone in the country would receive a first dose by October.
In…
-
Business23 hours agoForget CBA and buy these high-yield ASX dividend shares
-
General23 hours agoUK PM ready to ‘shelter’ businesses from tariff storm
-
General23 hours agoWhy do states and territories have different school holidays?
-
Business24 hours agoHere’s a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!